Early Release of Chromogranin A (CgA)

Clinical trial pipeline · Data from ClinicalTrials.gov

Total trials

Actively recruiting

Phase 3 trials

Completed

The results of the study suggest that an early change in CgA levels might serve as a prognostic factor in NET patients treated with PRRT.